<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did CSBR's Q4 2024 EPS outperform forecasts?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/10/2025 08:11pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Champions Oncology (CSBR) reported an EPS of $0.17 for Q4 2024, which represents a significant positive surprise compared to the forecast. This indicates that the company's performance for the period exceeded market expectations, likely due to factors such as effective cost management, revenue growth, or strategic initiatives.


|code|Ticker|Name|Date|EPS Surprise|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|CSBR|CSBR.O|Champions Oncology|2024 Q1|-0.06|-0.19|186|
|CSBR|CSBR.O|Champions Oncology|2024 Q2|0.02|-0.15|186|
|CSBR|CSBR.O|Champions Oncology|2024 Q3|-0.1|-0.19|186|
|CSBR|CSBR.O|Champions Oncology|2024 Q4|0.17||186|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:S,comeFrom:"AInvestShareLink",events:[],answerSource:p}],fetch:{},error:q,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:h,agent_id:a,output_media_info:[],task_id:a,language:a,source:p,cache_builder:a,reply_action:"Answer",execute_mode:H,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did CSBR's Q4 2024 EPS outperform forecasts?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did CSBR's Q4 2024 EPS outperform forecasts?\",\"user_id\":\"dp77824768\",\"user_name\":\"\",\"trace_id\":\"dfc87ccf-bdbb-4391-9cb5-c9f0b2df843f\",\"session_id\":\"dfc87ccf-bdbb-4391-9cb5-c9f0b2df843f\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:j,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Diluted EPS[20241231]|EPS Surprise[20241231]|\n|---|---|---|---|---|---|\n|CSBR|Champions Oncology|$8.46|8.46%||0.17|\n",query_data:{number:h,title:I,query_type:j,condition:a,model_sql:T,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:e}}}],answer_chain_name:U,agent_mode:V,native_answer:a,come_from:a,text_answer:S,trace_id:i,cost:14937,event_names:a,question:g,fallback_type:W,input_type:X,fall_back_reason:{fall_back_type:W,risk_detail:{matched_words:[]}},session_id:i,first_return_cost:2937,cache_type:a,question_id:i,transfer_question:g,signal_type:"ON_COMPLETE",start_time:Y,remote_svc:p,slots:[],answer_type:H,user_id:z,skill_name:J},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:z,question:g,source:p,raw_question:g,version:"3.4.1",action_name:J,nlu:{entity:[{type:Z,value:r,market:k}]},deep_research:c,deep_thinking:c,agent_mode:V},extra:{}},{answer_path:A,section:{id:B,info_texts:["Thinking"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:A,section:{id:B,info_texts:["Querying Stock: CSBR EPS in Fiscal 2024 Q4, EPS Surprise in Fiscal 2024 Q4"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:I,thought:"The user wants to evaluate how well CSBR's Q4 2024 EPS exceeded forecasts. I should focus on the company's Q4 2024 EPS and EPS surprise. I will use FinQuery for the data mentioned above."}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:A,section:{id:B,info_texts:["Generating Answer"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:"Ch",text_answer:_,rich_text:_,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:t,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:I,query_type:j,trace_data:a,index:h,model_sql:T,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:e},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:". This",text_answer:$,rich_text:$,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:u,market_id:k,name:n,domain:Z},pos:e,section_id:m,txt:n,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:"\n",text_answer:aa,rich_text:aa,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:ab,choice:[],result_page:{components:[{uuid:"ef1694d62910f967",config:{score:115.5,show_type:ac,scoreRuleNames:"value_unit;data_size;value_unit;",showDataZoom:b,show_type_id:201,title:"柱折图",render:{ry:[{type:"line",key:D}],x:v,ly:[{type:"bar",key:E}]},title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ad,h2:a},show_type:K}},data:{chunks_info:"[]",code_count:h,columns:[{index_name:L,key:L,label:"hq_code",source:M,type:f},{domain:F,feKey:N,index_name:N,key:N,label:L,origin_index:"stock code",source:M,type:f,unit:a},{domain:F,feKey:O,index_name:O,key:O,label:"name",origin_index:"stock name",source:M,type:f,unit:a},{feKey:v,index_name:v,key:v,label:"date",origin_index:v,type:"DATE"},{domain:F,feKey:D,index_name:D,key:D,label:a,source:a,timestamp:a,type:ae,unit:a},{domain:F,feKey:E,index_name:E,key:E,label:a,source:a,timestamp:a,type:ae,unit:"USD"},{index_name:af,key:af,type:f}],condition:"[{\"sonSize\":4,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL CSBR.O\"],\"indexPropertiesMap\":{\"EQUAL\":\"CSBR.O\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":2,\"opName\":\"or\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@EPS Surprise\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Diluted EPS\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20241231\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20241231\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:4,datas:[{code:u,Ticker:r,"EPS Surprise":-.06,"Diluted EPS":ag,market_code:k,Date:"2024 Q1",Name:n},{code:u,Ticker:r,"EPS Surprise":.02,"Diluted EPS":-.15,market_code:k,Date:"2024 Q2",Name:n},{code:u,Ticker:r,"EPS Surprise":-.1,"Diluted EPS":ag,market_code:k,Date:"2024 Q3",Name:n},{code:u,Ticker:r,"EPS Surprise":.17,market_code:k,Date:"2024 Q4",Name:n}],meta:{extra:{}},row_count:h,status_code:e,status_msg:"ok"},category:"generic",chart_type:"barLine",show_type:ac,title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ad,h2:a},show_type:K},support_refresh:b,data_config:{query:a,query_type:j,data_ext_params:{}}}],global:{query_type:j},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"barline3\",\"uuid\":\"ef1694d62910f967\"}]"},render_for:P},data_config:{query:a,query_type:j,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"e496b4b1-6dd1-499a-a6b9-4e34a3423148"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:A,section:{id:B,info_texts:["Completed"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:ab,choice:[{display_text:w,query_text:w,trace_info:{item_id:"e4f6a80947a11c23c8407c7840957994",item_type:o,item_name:w,rec_info:ah}},{display_text:x,query_text:x,trace_info:{item_id:"28c82ed0dcc53c7c84038c8c02322306",item_type:o,item_name:x,rec_info:ai}},{display_text:y,query_text:y,trace_info:{item_id:"450dd96593dc034fef5614ebbbfe3316",item_type:o,item_name:y,rec_info:aj}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:K,data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:ak,related_name:al}],puuid:Q,tag:a,category:"custom",uuid:am}],global:{urp_static_data:[{name:al,value:{status_code:e,columns:[{type:f,index_name:an,key:an},{type:f,index_name:ao,key:ao},{type:f,index_name:ap,key:ap},{type:f,index_name:aq,key:aq},{type:f,index_name:ar,key:ar}],datas:[{send_text:w,item_type:o,rec_info:ah,display_text:w,rec_reason:a},{send_text:x,item_type:o,rec_info:ai,display_text:x,rec_reason:a},{send_text:y,item_type:o,rec_info:aj,display_text:y,rec_reason:a}],dataSize:ak,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:as,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:G,"min-height":"100%",position:at,height:G},isMaterial:c,id:as,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:R,componentUuid:am,script:[{name:au,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:R,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:R},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:G,position:at,height:G},isMaterial:b,_id:19,id:au,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:P,voice_txt:a,tracking_info:{},uuid:Q},order:{is_auto:c,render_for:P,chart_type:"command",puuid:Q}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:J,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:H,answer_chain_name:U},is_deep_research:c,deep_thinking:c,create_time:1744287130736},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:q,docsData:[],quoteData:q},tplType:"question"},events:av,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:av,client_ip:a,question:g,user_id:z,user_name:a,trace_id:i,session_id:i,source:p,input_type:X}}],userId:z,userName:a,startTime:Y,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:q,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:q,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-csbrs-q4-2024-eps-outperform-forecasts-e34d35\u002F",config:{_app:{basePath:aw,assetsPath:aw,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,"STR","How did CSBR's Q4 2024 EPS outperform forecasts?",1,"dfc87ccf-bdbb-4391-9cb5-c9f0b2df843f","intusstock","186","signal",2001,"Champions Oncology","llm_generated","ths_ainvest_lite_web",null,"CSBR.O",999,"rich_text","CSBR","Date","What are the analyst expectations for CSBR's Q1 2025 earnings?","What is the current market sentiment towards CSBR's stock?","How did CSBR's operating expenses compare to Q3 2024?","dp77824768","progress\u002Fsearching_for",1000,"searching_for","EPS Surprise","Diluted EPS","abs_国际美股领域","auto","agent","CSBR EPS in Fiscal 2024 Q4, EPS Surprise in Fiscal 2024 Q4","explain news events","title1","code","fixed_index","Ticker","Name","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Champions Oncology (CSBR) reported an EPS of $0.17 for Q4 2024, which represents a significant positive surprise compared to the forecast. This indicates that the company's performance for the period exceeded market expectations, likely due to factors such as effective cost management, revenue growth, or strategic initiatives.\n\n\n|code|Ticker|Name|Date|EPS Surprise|Diluted EPS|market_code|\n|---|---|---|---|---|---|---|\n|CSBR|CSBR.O|Champions Oncology|2024 Q1|-0.06|-0.19|186|\n|CSBR|CSBR.O|Champions Oncology|2024 Q2|0.02|-0.15|186|\n|CSBR|CSBR.O|Champions Oncology|2024 Q3|-0.1|-0.19|186|\n|CSBR|CSBR.O|Champions Oncology|2024 Q4|0.17||186|\n\n","select   stock_code,   diluted_eps from   ustock_fin_data where   fiscal_date = date('2024y4q')   and stock_code = 'CSBR.O' intersect select   stock_code,   eps_surprise from   ustock_fin_forecast where   fiscal_date = date('2024y4q')   and stock_code = 'CSBR.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1744287115799,"stock","Champions Oncology (CSBR) reported an EPS of $0.17 for Q4 2024, which represents a significant positive surprise compared to the forecast[^1]",". This indicates that the company's performance for the period exceeded market expectations, likely due to factors such as effective cost management, revenue growth, or strategic initiatives.\n\n","\n``` visual\n{\"uuid\":\"e496b4b1-6dd1-499a-a6b9-4e34a3423148\"}\n```","result_page","barline3","CSBR EPS Surprise, Diluted EPS","DOUBLE","market_code",-.19,"2+679_496_21_554+0+0+dfc87ccf-bdbb-4391-9cb5-c9f0b2df843f+e4f6a80947a11c23c8407c7840957994+llm_generated+aimeTagAnalysis+0+0.04650557041168213+1","2+679_496_21_554+0+0+dfc87ccf-bdbb-4391-9cb5-c9f0b2df843f+28c82ed0dcc53c7c84038c8c02322306+llm_generated+aimeTagAnalysis+0+0.03915165364742279+2","2+679_496_21_554+0+0+dfc87ccf-bdbb-4391-9cb5-c9f0b2df843f+450dd96593dc034fef5614ebbbfe3316+llm_generated+aimeTagAnalysis+0+0.03636391460895538+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>